EcoDrugPlus

Ensembl ID : ENSOMEG00000011042
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSOMEG00000012139
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSOMEG00000012164
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSOMEG00000017972
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSOMEG00000023316
Gene Symbol: RPS3A
1 Cross references
359 Possible Orthologues:

Ensembl ID : ENSOMEG00000006659
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSOMEG00000020652
Gene Symbol: -
Cross references: -
331 Possible Orthologues:

Ensembl ID : ENSOMEG00000013348
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSOMEG00000016529
Gene Symbol: -
Cross references: -
168 Possible Orthologues:

Ensembl ID : ENSOMEG00000020159
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSOMEG00000007799
Gene Symbol: -
Cross references: -
216 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).